Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Community Health Systems
CYH
$419M
| $3.47M | ﹤0.01% |
1,197,727
-22,162
| -2% | -$76.7K |
|
2802
National Bankshares
NKSH
$272M
| $3.47M | ﹤0.01% |
77,276
-2,100
| -3% | -$90.1K |
|
|
MTEM
2803
DELISTED
Molecular Templates, Inc.
MTEM
| $3.47M | ﹤0.01% |
16,553
+2,175
| +15% | +$313K |
|
|
MCBC
2804
DELISTED
Macatawa Bank Corp
MCBC
| $3.46M | ﹤0.01% |
311,213
-8,644
| -3% | -$92.1K |
|
|
AHT
2805
Ashford Hospitality Trust
AHT
$20.2M
| $3.46M | ﹤0.01% |
1,241
-33
| -3% | -$92.4K |
|
2806
Inovio Pharmaceuticals
INO
$93M
| $3.46M | ﹤0.01% |
87,233
-8,909
| -9% | -$268K |
|
2807
Business First Bancshares
BFST
$1.05B
| $3.44M | ﹤0.01% |
137,985
-3,287
| -2% | -$80.7K |
|
2808
uniQure
QURE
$3.26B
| $3.42M | ﹤0.01% |
47,658
+2,734
| +6% | +$150K |
|
2809
Paysign
PAYS
$735M
| $3.41M | ﹤0.01% |
336,258
-9,400
| -3% | -$98.8K |
|
2810
Gerdau
GGB
$9.42B
| $3.41M | ﹤0.01% |
877,550
+164,958
| +23% | +$491K |
|
2811
Southern Missouri Bancorp
SMBC
$850M
| $3.41M | ﹤0.01% |
88,823
-2,581
| -3% | -$95.5K |
|
2812
Geospace Technologies
GEOS
$66.5M
| $3.4M | ﹤0.01% |
202,913
-5,646
| -3% | -$85.8K |
|
2813
SmartFinancial
SMBK
$899M
| $3.4M | ﹤0.01% |
143,687
-2,947
| -2% | -$64.8K |
|
2814
Atlanta Braves Holdings Series A
BATRA
$3.64B
| $3.39M | ﹤0.01% |
114,230
-4,505
| -4% | -$128K |
|
2815
Adaptive Biotechnologies
ADPT
$3.89B
| $3.38M | ﹤0.01% |
112,993
-701
| -0.6% | -$20.1K |
|
2816
iShares ESG Optimized MSCI USA ETF
SUSA
$4.21B
| $3.38M | ﹤0.01% |
50,400
| – | – |
|
2817
Cameco
CCJ
$42.6B
| $3.37M | ﹤0.01% |
378,669
-2,091
| -0.5% | -$19.3K |
|
2818
Kornit Digital
KRNT
$827M
| $3.37M | ﹤0.01% |
98,362
-22,359
| -19% | -$741K |
|
2819
Distribution Solutions Group
DSGR
$1.61B
| $3.36M | ﹤0.01% |
129,020
+1,696
| +1% | +$40.1K |
|
2820
Vanguard Russell 2000 ETF
VTWO
$17.5B
| $3.36M | ﹤0.01% |
50,488
-6,102
| -11% | -$388K |
|
2821
Northrim BanCorp
NRIM
$601M
| $3.35M | ﹤0.01% |
349,992
-12,924
| -4% | -$124K |
|
2822
Mitek Systems
MITK
$853M
| $3.34M | ﹤0.01% |
436,945
-12,298
| -3% | -$104K |
|
|
HUYA
2823
Huya Inc
HUYA
$538M
| $3.34M | ﹤0.01% |
186,041
+159,300
| +596% | +$3.37M |
|
|
TBIO
2824
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $3.34M | ﹤0.01% |
410,092
+72,906
| +22% | +$673K |
|
|
LAND
2825
Gladstone Land Corp
LAND
$358M
| $3.33M | ﹤0.01% |
256,829
+11,913
| +5% | +$146K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.